Drugs / cyclic di-adenosine monophosphate
last change Nov 2022 re-read 3 minutes ago

cyclic di-adenosine monophosphate

also known as c-di-AMP · cdA · cyclic di-AMP

Oligonucleotide (other)

Investigated by
German Cancer Research Center · National Center for Tumor Diseases, Heidelberg · University Hospital Heidelberg

Trials 1

202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05208710 Nov 2022 → Dec 2027 expected human papilloma virus infection German Cancer Research Center Recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as cyclic di-adenosine monophosphate “the di-nucleotide adjuvant cyclic di-adenosine monophosphate (used abbreviations: cyclic di-AMP / c-di-AMP/ cdA), an inducer of cellular STING” NCT05208710 ↗
Known as c-di-AMP “the di-nucleotide adjuvant cyclic di-adenosine monophosphate (used abbreviations: cyclic di-AMP / c-di-AMP/ cdA), an inducer of cellular STING” NCT05208710 ↗
Known as cdA “the di-nucleotide adjuvant cyclic di-adenosine monophosphate (used abbreviations: cyclic di-AMP / c-di-AMP/ cdA), an inducer of cellular STING” NCT05208710 ↗
Known as cyclic di-AMP “the di-nucleotide adjuvant cyclic di-adenosine monophosphate (used abbreviations: cyclic di-AMP / c-di-AMP/ cdA), an inducer of cellular STING” NCT05208710 ↗
Action Activate “an inducer of cellular STING” NCT05208710 ↗
Modality Oligonucleotide (other) “the di-nucleotide adjuvant cyclic di-adenosine monophosphate” NCT05208710 ↗